News

The IMPLEMENT study explored why first-line treatment intensification remains underutilised and how clinicians’ behaviours, beliefs, and environments influence its uptake.

EACS 2025 data show over half of HIV diagnoses among migrants in Switzerland occur post-migration, highlighting need for targeted testing and prevention.

Researchers reveal an innovative toothbrush that uses smartphone integration and AI to visualise and reduce dental plaque instantly.

The review revealed that patients consistently prioritise rapid symptom relief, preferably within two weeks, alongside long-term control of hives, itching, and swelling.

A new clinical trial shows food subsidies are more effective than meal boxes in supporting a healthy blood pressure diet.

EACS 2025 study shows minimal HBV reactivation after stopping tenofovir in people with HIV, supporting safe use of tenofovir-sparing ART.

A new study shows paternal SARS-CoV-2 infection changes sperm RNA and increases anxiety-like behaviour in offspring, revealing intergenerational effects.

New EACS data show once-weekly islatravir and lenacapavir maintain HIV viral suppression for 96 weeks with no resistance or major side effects.